POSC258 Acceptance of Progression-Free Survival 2 (PFS2) By EU5 and Canadian Health Authorities for Cancer Drug Reimbursement
Jan 1, 2022, 00:00 AM
10.1016/j.jval.2021.11.896
https://www.valueinhealthjournal.com/article/S1098-3015(21)02691-7/fulltext
Section Title :
Section Order :
10427
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)02691-7&doi=10.1016/j.jval.2021.11.896